BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25181933)

  • 1. Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.
    Bell LN; Wulff J; Comerford M; Vuppalanchi R; Chalasani N
    Liver Int; 2015 Jan; 35(1):263-74. PubMed ID: 25181933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
    Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
    J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases.
    Walker DI; Juran BD; Cheung AC; Schlicht EM; Liang Y; Niedzwiecki M; LaRusso NF; Gores GJ; Jones DP; Miller GW; Lazaridis KN
    Hepatol Commun; 2022 May; 6(5):965-979. PubMed ID: 34825528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycan biomarkers of autoimmunity and bile acid-associated alterations of the human glycome: Primary biliary cirrhosis and primary sclerosing cholangitis-specific glycans.
    Maverakis E; Merleev AA; Park D; Kailemia MJ; Xu G; Ruhaak LR; Kim K; Hong Q; Li Q; Leung P; Liakos W; Wan YY; Bowlus CL; Marusina AI; Lal NN; Xie Y; Luxardi G; Lebrilla CB
    Clin Immunol; 2021 Sep; 230():108825. PubMed ID: 34403816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.
    Sarcognato S; Sacchi D; Grillo F; Cazzagon N; Fabris L; Cadamuro M; Cataldo I; Covelli C; Mangia A; Guido M
    Pathologica; 2021 Jun; 113(3):170-184. PubMed ID: 34294935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis.
    Landi A; Weismuller TJ; Lankisch TO; Santer DM; Tyrrell DL; Manns MP; Houghton M
    J Interferon Cytokine Res; 2014 Mar; 34(3):204-14. PubMed ID: 24168449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
    Ahn DW
    Korean J Gastroenterol; 2020 May; 75(5):246-256. PubMed ID: 32448856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.
    Bernuzzi F; Marabita F; Lleo A; Carbone M; Mirolo M; Marzioni M; Alpini G; Alvaro D; Boberg KM; Locati M; Torzilli G; Rimassa L; Piscaglia F; He XS; Bowlus CL; Yang GX; Gershwin ME; Invernizzi P
    Clin Exp Immunol; 2016 Jul; 185(1):61-71. PubMed ID: 26864161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis.
    Tietz-Bogert PS; Kim M; Cheung A; Tabibian JH; Heimbach JK; Rosen CB; Nandakumar M; Lazaridis KN; LaRusso NF; Sung J; O'Hara SP
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30332763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol.
    Ghonem NS; Auclair AM; Hemme CL; Gallucci GM; de la Rosa Rodriguez R; Boyer JL; Assis DN
    Clin Pharmacol Ther; 2020 Dec; 108(6):1213-1223. PubMed ID: 32480421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients.
    Kruk B; Milkiewicz M; Raszeja-Wyszomirska J; Milkiewicz P; Krawczyk M
    Orphanet J Rare Dis; 2022 Nov; 17(1):419. PubMed ID: 36397154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese and copper levels in patients with primary biliary cirrhosis and primary sclerosing cholangitis.
    Dastych M; Husová L; Aiglová K; Fejfar T; Dastych M
    Scand J Clin Lab Invest; 2021 Apr; 81(2):116-120. PubMed ID: 33428478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
    Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
    Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease.
    Pihusch R; Rank A; Göhring P; Pihusch M; Hiller E; Beuers U
    J Hepatol; 2002 Nov; 37(5):548-55. PubMed ID: 12399218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.
    Franco J; Saeian K
    Curr Gastroenterol Rep; 1999 Apr; 1(2):95-101. PubMed ID: 10980934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
    Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
    J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
    Mattner J
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis.
    Zhou X; Kailemia MJ; Sun Y; Shuai Z; Yang GX; Dhaliwal S; Cristoferi L; Leung PSC; Invernizzi P; Bowlus CL; Lebrilla CB; Ansari AA; Ridgway WM; Zhang W; Gershwin ME
    J Autoimmun; 2020 Sep; 113():102503. PubMed ID: 32546343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis.
    ter Borg PC; Fekkes D; Vrolijk JM; van Buuren HR
    BMC Gastroenterol; 2005 Mar; 5():11. PubMed ID: 15790420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.